Equities analysts expect that Baxter International Inc (NYSE:BAX) will report earnings per share (EPS) of $0.84 for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Baxter International’s earnings, with the lowest EPS estimate coming in at $0.83 and the highest estimate coming in at $0.86. Baxter International reported earnings per share of $0.80 during the same quarter last year, which would suggest a positive year-over-year growth rate of 5%. The company is scheduled to report its next quarterly earnings report on Wednesday, October 30th.
According to Zacks, analysts expect that Baxter International will report full year earnings of $3.37 per share for the current fiscal year, with EPS estimates ranging from $3.32 to $3.39. For the next year, analysts expect that the business will post earnings of $3.78 per share, with EPS estimates ranging from $3.72 to $3.92. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Baxter International.
Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.08. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The firm had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.80 billion. During the same period in the previous year, the business earned $0.77 earnings per share. The firm’s revenue for the quarter was down .1% on a year-over-year basis.
Shares of Baxter International stock traded down $0.38 during trading hours on Friday, hitting $84.70. The company’s stock had a trading volume of 1,573,832 shares, compared to its average volume of 2,310,100. Baxter International has a twelve month low of $61.05 and a twelve month high of $86.65. The company’s fifty day simple moving average is $82.31. The company has a market cap of $43.44 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 1.97 and a beta of 1.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.30 and a current ratio of 2.78.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be given a dividend of $0.22 per share. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $0.88 annualized dividend and a dividend yield of 1.04%. Baxter International’s dividend payout ratio is presently 28.85%.
In other Baxter International news, SVP Jacqueline Kunzler sold 593 shares of the business’s stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $80.46, for a total transaction of $47,712.78. Following the sale, the senior vice president now directly owns 9,023 shares of the company’s stock, valued at approximately $725,990.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Third Point Llc sold 5,000,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $76.37, for a total transaction of $381,850,000.00. The disclosure for this sale can be found here. Insiders sold 5,001,913 shares of company stock valued at $382,000,950 over the last 90 days. 0.70% of the stock is currently owned by insiders.
Large investors have recently modified their holdings of the stock. Weaver Consulting Group bought a new stake in Baxter International in the first quarter worth $25,000. C J Advisory Inc bought a new stake in shares of Baxter International in the first quarter valued at about $28,000. Personal Wealth Partners bought a new stake in shares of Baxter International in the second quarter valued at about $29,000. TRUE Private Wealth Advisors acquired a new position in Baxter International in the second quarter worth about $29,000. Finally, Evolution Wealth Advisors LLC acquired a new position in Baxter International in the second quarter worth about $32,000. Hedge funds and other institutional investors own 83.87% of the company’s stock.
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
Featured Story: Leveraged Buyout (LBO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.